We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-8.37%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$5.28B
AUM Growth
-$1.41B
Cap. Flow
-$1.19B
Cap. Flow %
-22.61%
Top 10 Hldgs %
53.54%
Holding
466
New
23
Increased
24
Reduced
24
Closed
360

Top Buys

Rank Stock Value
1
NAMS icon
NewAmsterdam Pharma
NAMS
+$72.5M
2
LEGN icon
Legend Biotech
LEGN
+$64.3M
3
OSCR icon
Oscar Health
OSCR
+$64.1M
4
DVAX
Dynavax Technologies
DVAX
+$62.6M
5
INDV icon
Indivior Pharmaceuticals
INDV
+$39M

Top Sells

Rank Stock Value
1
NUVL
Nuvalent
NUVL
+$187M
2
KURA icon
Kura Oncology
KURA
+$106M
3
CPRX
Catalyst Pharmaceutical
CPRX
+$66.5M
4
SGRY icon
Surgery Partners
SGRY
+$57.4M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$56.2M

Sector Composition

Rank Sector Weight
1 Healthcare 87.97%
2 Industrials 0.23%
3 Consumer Staples 0.01%
4 Energy 0%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MUR icon
301
Murphy Oil
MUR
$5.55B
– –
-10,243
Closed -$346K
NBBK icon
302
NB Bancorp
NBBK
$993M
– –
-46,371
Closed -$861K
NEO icon
303
NeoGenomics
NEO
$1.99B
– –
-9,486
Closed -$140K
NKE icon
304
Nike
NKE
$64.1B
– –
-9,310
Closed -$823K
NNN icon
305
NNN REIT
NNN
$9.29B
– –
-8,891
Closed -$431K
NOC icon
306
Northrop Grumman
NOC
$76B
– –
-1,294
Closed -$683K
NTNX icon
307
Nutanix
NTNX
$16.1B
– –
-16,429
Closed -$973K
NVAX icon
308
Novavax
NVAX
$1.21B
– –
-92,597
Closed -$1.17M
NVDA icon
309
NVIDIA
NVDA
$4.6T
– –
-16,318
Closed -$1.98M
NVRI icon
310
Enviri
NVRI
$624M
– –
-82,364
Closed -$852K
NWN icon
311
Northwest Natural Holdings
NWN
$2.15B
– –
-9,940
Closed -$406K
NXPI icon
312
NXP Semiconductors
NXPI
$60.8B
– –
-1,496
Closed -$359K
ODFL icon
313
Old Dominion Freight Line
ODFL
$46.3B
– –
-7,199
Closed -$1.43M
OHI icon
314
Omega Healthcare
OHI
$15.3B
– –
-9,509
Closed -$387K
OI icon
315
O-I Glass
OI
$1.18B
– –
-62,673
Closed -$822K
OKE icon
316
Oneok
OKE
$56.7B
– –
-5,970
Closed -$544K
OLMA icon
317
Olema Pharmaceuticals
OLMA
$977M
– –
-33,296
Closed -$398K
OMCL icon
318
Omnicell
OMCL
$1.88B
– –
-17,651
Closed -$770K
ONTO icon
319
Onto Innovation
ONTO
$10.9B
– –
-1,073
Closed -$223K
OPCH icon
320
Option Care Health
OPCH
$3.76B
– –
-23,613
Closed -$739K
OPK icon
321
Opko Health
OPK
$1.02B
– –
-22,796
Closed -$34K
ORI icon
322
Old Republic International
ORI
$10.9B
– –
-12,645
Closed -$448K
ORIC icon
323
Oric Pharmaceuticals
ORIC
$1.17B
– –
-78,435
Closed -$804K
OTTR icon
324
Otter Tail
OTTR
$3.81B
– –
-22,452
Closed -$1.75M
OXM icon
325
Oxford Industries
OXM
$581M
– –
-18,184
Closed -$1.58M
11 12
13
14 15

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q4 2024 Portfolio in Review

As of Q4 2024, Deerfield Management held 466 positions worth $5.28B, down 21% from $6.69B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Deerfield Management withdrew a net $1.19B in Q4 2024, closing 360 positions and reducing 24 holdings. Its most notable exit was Kura Oncology, an estimated $106M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, up from 87% a quarter earlier, followed by Industrials and Consumer Staples.

Against the trend, Deerfield Management opened a new position in Legend Biotech worth $50.5M.

  • Deerfield Management's largest Q4 2024 buy was Legend Biotech: 1,551,718 shares worth $50.5M.
  • Deerfield Management added most to NewAmsterdam Pharma in Q4 2024, an estimated $72.5M increase.
  • Deerfield Management's biggest Q4 2024 reduction was Nuvalent, cutting an estimated $187M.
  • Deerfield Management fully exited Kura Oncology in Q4 2024, selling an estimated $106M.
  • Deerfield Management's ten largest holdings make up 54% of its $5.28B portfolio in Q4 2024.
  • Deerfield Management opened 23 new positions and closed 360 in Q4 2024.
  • Deerfield Management's portfolio value fell 21% quarter-over-quarter to $5.28B.

Based on Deerfield Management's 13F filing for Q4 2024, filed 14 Feb 2025.